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Background: Probiotic supplementation can reduce mutans streptococci (MS) numbers. One of its proposed
mechanisms is immunomodulation. Salivary human neutrophil peptide 1–3 (HNP1-3) levels have previously been
demonstrated to be higher in caries-free than in caries-susceptible children, suggesting their preventive role against
caries. We aimed to compare salivary HNP1-3 levels between an intervention group with probiotics and a control
group.
Methods: A randomized double-blinded clinical trial was conducted. Sixty schoolchildren were equally allocated to
either an intervention or control group. The use of a probiotic strain, Lactobacillus paracasei SD1, has shown to
reduce MS numbers in volunteers. In unstimulated whole saliva, HNP1-3 levels were assayed by ELISA, and MS and
lactobacilli counts were assayed by colony counting at baseline (T0) and at 3 (T3), 6 (T6), and 12 months (T12). The
International Caries Detection and Assessment system was used to assess caries status.
Results: In the intervention group, salivary HNP1-3 levels were significantly greater than those in the control group
at T3 and T6 (p < 0.001), whereas MS counts were significantly decreased (p < 0.01). In the intervention group,
positive and negative correlations were found between HNP1-3 levels and lactobacilli counts and between MS and
lactobacilli counts, respectively. However, there was no significant correlation between enhanced HNP1-3 levels and
decreased MS numbers. The caries increment for the pit and fissure surface, but not for the smooth surfaces, was
significantly decreased in the intervention group compared with the control group (p = 0.01).
Conclusions: Probiotics can temporarily enhance salivary HNP1-3 levels; however, their action to reduce new pit
and fissure caries probably involves microbial interactions.
Trial registration: TCTR20130904001 (registration date: September 04, 2013).
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Dental caries is one of the most prevalent diseases in
both children and adults worldwide [1]. However, the
success of all caries preventive programs has been im-
peded by its multifactorial nature. The disease is a result
of demineralization, caused by the interactions of cario-
genic bacteria, a diet rich in fermentable carbohydrates,
and host components, such as tooth and saliva proper-
ties [2]. Although many bacterial species can play a role* Correspondence: suttichai.k@cmu.ac.th
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unless otherwise stated.in the caries process [3], mutans streptococci (MS) have
been considered major pathogens associated with early
caries development [4]. The main virulence properties of
MS are acidogenicity, acid tolerance, biofilm formation
and tooth adhesion [5]. Strong association between MS
quantities and the pathogenesis of dental caries is dem-
onstrated by several previous studies, reviewed in [6].
Probiotic administration is considered a potential strat-
egy for improving or maintaining oral health. According
to the World Health Organization (WHO), probiotics are
“live microorganisms which, when administered in ad-
equate amounts, confer a health benefit on the host” [7].
Several mechanisms have been proposed for the probiotic
action, including production of antimicrobial substances,tral. This is an Open Access article distributed under the terms of the Creative
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sion and invasion, and modulation of local and systemic
immune functions [8-11]. In a recent systematic review
[12], several clinical trials have shown the capacity of pro-
biotic supplementation to reduce MS counts, but the de-
creasing effect is variable and short-lasting. Moreover,
only very few studies have so far investigated the quan-
tities of lactobacilli (LB) and the prevention of new caries
occurrence by probiotic supplementation.
Although LB, commonly used as probiotics, have been
associated with caries progression [13], a recent study
has revealed that only a certain species, i.e., Lactobacil-
lus salivarius, is more related to caries development by
its ability to produce high levels of acids [14]. In contrast
to these cariogenic bacteria, Lactobacillus paracasei iso-
lated from caries-free subjects possesses an ability to
suppress MS growth [15,16]. In this study, Lactobacillus
paracasei SD1 was introduced as a probiotic strain and
used in the oral cavity because of its several previously-
demonstrated properties, including inhibition of MS
growth, less acid production than other LB, and good
adherence to oral epithelial cells [17].
Human neutrophil peptides 1–3 (HNP1-3) are small
cationic antimicrobial peptides that provide the first line
of host defense against a broad spectrum of microorgan-
isms [18]. HNP1-3 are expressed in ductal epithelial cells
of submandibular salivary glands and secreted into saliva
[19]. They are also produced by neutrophils and released
into gingival crevicular fluid [20]. The preventive role of
HNP1-3 against dental caries has been suggested by the
significantly higher salivary HNP1-3 levels in caries-free
children than in those experiencing caries demonstrated
by Tao et al. [19]. Since one of the probiotic mechanisms
has been proposed to be involved with host immune
regulation, we, therefore, hypothesized that probiotic
supplementation might help prevent dental caries by
augmentation of local host immunity via enhanced pro-
duction of salivary HNP1-3. The aims of this study were
to examine the effects of probiotic intervention on saliv-
ary HNP1-3 levels, MS counts, and LB counts, and to
determine the correlations between these host and mi-
crobial parameters. Furthermore, new occurrences of
carious lesions for the second permanent molars during
a 12-month clinical trial were assessed and compared
between the control and intervention groups.
Methods
Overview of study design
This trial was designed as a randomized, double-blinded
and placebo-controlled method with two parallel groups.
The study protocol was approved by the Human Experi-
mentation Committees of the Faculties of Dentistry,
Chiang Mai University and Prince of Songkla University,
Thailand. Informed consent was obtained from theparents or guardians of each participant before the com-
mencement of this study. Sixty eligible and healthy par-
ticipants out of 246 children were allocated equally to
either of the two groups, the control and probiotic
groups, using a simple randomization procedure by
means of drawing lots (Figure 1). The inclusion and ex-
clusion criteria are identified in Participants and in
Figure 1. For the double-blinded method, the code
was kept by an independent monitor. This code was
not unveiled until all data had been analyzed. None of
the researchers, the clinicians, the participants, the
teachers, or the statistician knew whether the children
received control or intervention milk throughout the
entire course of this study. The trial was registered at
the http://www.clinicaltrials.in.th/, one of the primary
WHO Registry Networks, Clinical Trials identifier
TCTR20130904001. The whole experimental period
lasted for 12 months, and the outcome measurement of this
study consisted of four parameters: salivary HNP1-3, MS
and LB levels at four different time points: T0 (baseline), T3
(three months of intervention), T6 (six months of inter-
vention) and T12 (six months after cessation of the
intervention), and the presence of carious or deminera-
lized lesions at T0 and T12 (Figure 1). The priori sam-
ple size calculation was performed with a focus on
mean differences of MS counts between two independ-
ent groups using G Power software [21], with the effect
size equal to 0.8 at 5% statistical significance level and
90% power of test. The calculation yielded no fewer
than 28 participants in each group.
Preparation of milk powder supplemented with probiotics
The probiotic strain, Lactobacillus paracasei SD1, was
isolated from caries-free volunteers and has been previ-
ously shown to exert the maximal inhibitory effect on
Streptococcus mutans in vitro [17]. The bacterial strain
was identified by PCR-RFLP of the 16S ribosomal RNA
gene and sodium dodecyl-polyacrylamide gel electro-
phoresis [22]. The probiotic intervention was manufac-
tured in a form of milk powder by the spray drying
technique. The culture conditions and the spray drying
technique were performed as previously described [23].
Briefly, a culture of Lactobacillus paracasei SD1 was in-
oculated in a mixture of 1% probiotics and a 3-liter
quantity of heat-treated (50°C for 30 min) and 20%
reconstituted skimmed milk, and then spray dried with a
spray dryer (model B191 Buchi mini spray dryer; Flawil,
Switzerland). The final product was yellowish white
powder with moisture contents of 3.44 ± 0.85% and vi-
able counts of 7.5 ± 0.20x108 cfu/g, which was stored at
4°C. The viability of Lactobacillus paracasei SD1 in the
inoculated milk powder was previously assessed in a six-
month study by examining its growth in triplicate Man
Rogosa and Sharpe (MRS) pour plates under anaerobic
Figure 1 A consort flow chart showing the number of participants in the control and probiotic groups at the beginning and
completion of the trial. Out of 246 children enrolled in this trial, 60 participants remained eligible due to the inclusion and exclusion criteria.
Sixty participants were equally allocated to either the control or the probiotic group by simple randomization described in the Methods. Participants
received milk powder with or without probiotics during the first six-month intervention, and saliva samples were collected for analyses of HNP1-3 levels,
MS and LB counts at four different time points: T0, T3, T6 and T12. Oral examination for evaluation of ICDAS scores was performed at T0 and T12.
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strated that the maximum survival rate of Lactobacillus
paracasei SD1 in the skimmed milk powder was 99% if
the milk powder was stored at 4°C for six months [23].
However, the survival rate declined sharply if the milk
powder was stored at 25°C [23]. The milk powder in
general appearance for both probiotic and control
groups looked identical, except for the absence of the
probiotic strain in the control group, and was packaged
in the same clear plastic bags marked with a name of
each participant. The packaging and delivering steps
were performed by a research assistant who was blinded
from every step of sampling and analyzing.
Participants
The inclusion criteria were: (i) good oral health with car-
ies in two or fewer teeth (ii) presence of four second
molars in the mouth (iii) absence of untreated active
deep carious lesions (iv) absence of periodontitis (v)
non-smoking and (vi) daily tooth brushing habit using
fluoride toothpaste. The exclusion criteria were teenagerswith systemic diseases, receiving systemic antibiotics
within six weeks, routine consumption of probiotics or
xylitol, allergy to cows’ milk, lactose intolerance and severe
food allergy. Prior to the commencement of the clinical
trial, all participants were informed not to consume any
products containing probiotics, such as yoghurt, drinking
yoghurt, cheese, etc., throughout the entire duration of
this trial. The participants in both groups were instructed
to mix 5 g of milk powder in 50 ml water and drink once
daily, except on the days of saliva collection, for six
months under the supervision of instructors. On the holi-
days or the weekends, all children were informed to drink
their milk at home and to return the empty plastic bags.
The compliance was checked by their teachers who filled
in a logbook every day with information on school attend-
ance of children and on whether or not the children had
been drinking the milk. It was apparent that no children
participating in this study were absent from their classes
due to sick leave during the first six-month intervention.
All participants were asked to immediately report any side
effects.
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A 2-ml quantity of unstimulated whole saliva was col-
lected and equally divided in two aliquots, one for ana-
lysis of HNP1-3 levels and the other for analysis of
microbiological levels. The first aliquot was added with
Nonidet P-40 (Sigma-Aldrich, St. Louis, MO) to the final
concentration of 0.1% (v/v), centrifuged at 15,000 rpm at
4°C for 10 min [19], and the cleared supernatant was
collected and stored frozen for further analysis of
HNP1-3 levels by an HNP1-3 ELISA kit (HyCult Bio-
technology, Uden, the Netherlands) according to the
manufacturer’s instruction. In brief, diluted saliva sam-
ples (1:200) were applied to a pre-coated plate in tripli-
cate with the specific primary antibody to HNP1-3, and
incubated for 1 h at room temperature. For a negative
control, dilution buffer without addition of the saliva
samples was added to the pre-coated plate. After wash-
ing four times with washing buffer, each well was incu-
bated with the biotinylated tracer antibody for 1 h at
room temperature. Then, the streptavidin-peroxidase
conjugate was added and incubated for 1 h. After that,
3,3′,5,5′-tetramethylbenzidine, a chromogenic substrate,
was added for 20 min, and the reaction was then
stopped by the addition of 2% oxalic acid. The concen-
trations of HNP1-3 in saliva samples were calculated
from a standard curve established by various known
concentrations of an HNP1-3 standard, used as the
ELISA system control. The concentrations of salivary
HNP1-3 were then normalized by their total protein
content using a BCA protein assay (Pierce Inc., Rock-
ford, IL) according to the manufacturer’s instruction.
Microbiological assays
The quantities of salivary MS and LB were evaluated by
a typical colony counting method at T0, T3, T6 and T12.
The second aliquot of saliva samples was ten-fold di-
luted from 1:10 to 1:10,000. Each dilution (10 μl) was
dropped onto the selective agar plates, Mitis Salivarius
Bacitracin (MSB) agar for MS (Difco Laboratories,
Detroit, MI) and MRS agar for LB (Difco Laboratories).
The conditions for incubation were anaerobic, 10% H2,
10% CO2 and 80% N2 at 37°C for 48 h. The colony
counting was performed under a microscope in
duplicate.
International Caries Detection and Assessment System
(ICDAS)
At the beginning and the end of this study (T0 and
T12), all participants were examined for oral health and
dental caries status by two experienced dentists (S.P. and
S.T.) with the Cohen’s kappa values 0.85 and 0.82 for the
intra- and inter-examiner calibrations, respectively. The
examination was performed by using a mouth mirror
and an air syringe under an operating light. The cariesdata for each tooth surface, including occlusal (pit and
fissure) and smooth surface (buccal, lingual, mesial and
distal) caries, were recorded according to the criteria of
the International Caries Detection and Assessment
System (ICDAS) [24]. The ICDAS codes consist of: 0 =
sound, 1 = first visual change in enamel, 2 = distinct
visual change in enamel, 3 = localized enamel break-
down, 4 = underlying dentin shadow, 5 = distinct cavity
with visible dentin, and 6 = extensive cavity within visible
dentin. Caries risk assessment in this study was deter-
mined by the modified criteria previously described by
Nase and co-workers [25], which include both clinical
caries status and MS quantities as follows. The “high
risk” participants were defined as having both an
ICDAS score >0 and MS levels ≥105 cfu/ml, whereas
the “moderate risk” ones had either an ICDAS score >0
or MS levels ≥105 cfu/ml and the “low risk” ones had
an ICDAS score =0 and MS levels <105 cfu/ml.
Statistical analyses
The Mann–Whitney U test was used to analyze inter-
group differences in salivary HNP1-3 levels. Differences
in salivary HNP1-3 levels among four different periods
in each group were analyzed by the Kruskal-Wallis test,
followed by the Mann–Whitney U test. The number of
colony counts for MS and that for LB were presented
as log cfu/ml and analyzed by the independent sample
t-test. Correlations between each pair of the data from
HNP1-3 levels, MS and LB counts in each group were
tested by the Pearson Correlation test. Regression ana-
lysis was performed for the significant correlation data.
An odds ratio (OR) for caries increment was calculated
by Crosstabulation. The software package used was the
Statistical Package for Social Sciences (SPSS version
17.0 Inc., Chicago, IL), and the differences were consid-
ered significant when p-values were less than 0.05. All




A total of 60 participants (age ranges 13–15 years; n = 26
for males and 34 for females) completed this 12-month
clinical trial (Figure 1). No adverse side effects from pro-
biotics or milk powder intake in this cohort were re-
ported. The compliance for daily consumption of milk
powder in both groups was carefully monitored under
the supervision of schoolteachers and well controlled
throughout the first six-month intervention period. The
assessment for caries risk revealed that the percentages
of participants classified in the “high risk”, the “moderate
risk” and the “low risk” groups were 50, 31.7 and 18.3,
respectively. Although the randomized procedure was
performed to allocate all 60 eligible participants to the
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percentages of high, moderate and low caries risk in the
control versus the probiotic group were almost equal as
follows: 50.0 versus 50.0, 33.3 versus 30.0, and 16.7 ver-
sus 20.0, respectively.
Raised salivary HNP1-3 levels in the probiotic group
The median salivary HNP1-3 levels, expressed in the
unit of μg/mg of total proteins, in the probiotic group
were significantly greater than those in the control group
at T3 (1.0250 versus 0.5145 μg/mg; p < 0.001) and T6
(1.1470 versus 0.5415 μg/mg; p < 0.001), but not at T0 or
T12 (Figure 2). With respect to the kinetics of salivary
HNP1-3 levels in the probiotic group during the 12-
month period of this clinical trial, it was demonstrated
that the HNP1-3 levels were temporarily elevated during
the six-month intervention period (Figure 2). In other
words, these levels were significantly increased at T3
and T6 (p < 0.001) and gradually declined at T12. How-
ever, no significant changes in salivary HNP1-3 levels in
the control group at four time points (T0, T3, T6 and
T12) were observed (Figure 2).
Decreased MS counts as opposed to increased LB counts
by probiotic intervention
The mean counts and standard errors for salivary MS
and LB (log cfu/ml) at T0, T3, T6 and T12 in the controlFigure 2 Significant but transient increase in salivary human
neutrophil peptide (HNP) 1–3 levels by probiotic supplementation.
The y-axis of box plot graph demonstrates salivary HNP1-3 levels
normalized by total protein concentration in the unit of μg/mg for
the control (empty boxes) and the probiotic (gray boxes) groups
from four different periods of saliva collection: T0, T3, T6 and T12.
* = p < 0.05; *** = p < 0.001. The solid lines show the significant
differences between two groups, while the dotted lines represent
the significant differences within the probiotic group.and probiotic groups are demonstrated in a linear graph
(Figure 3). At baseline (T0), it was demonstrated that the
mean salivary LB count in the probiotic group (a solid
line) was not significantly different from that in the con-
trol group (a dotted line), while the mean salivary MS
count in the probiotic group was significantly higher than
that in the control group (p < 0.05; Figure 3). However,
at T3 and T6, a significant reduction in MS counts in
the probiotic group was clearly evident when com-
pared with those in the control group (T3 = p < 0.001
and T6 = p < 0.01), whereas a significant increase in LB
counts was instead observed (p < 0.05; Figure 3). In
contrast to the probiotic group, no significant changes
in the mean counts for salivary MS and LB were found
in the control group (dotted lines in Figure 3). At T12,
the mean count for salivary MS in the probiotic group
was increased and returned almost to the baseline,
while the mean count for salivary LB in the probiotic
group was still significantly higher than that in the
control group (p < 0.01; Figure 3), suggesting the ability
of LB to be retained in the oral cavity despite cessation
of the probiotic intervention for six months.Significant reduction in the caries increment for the pit
and fissure surface in the probiotic group
The percentages of sound (ICDAS score =0) and un-
sound surfaces (ICDAS scores =1–6) from all five tooth
surfaces, including pit and fissure, mesial, distal, buccal,
and lingual, at T0 and T12 in both control and probiotic
groups are illustrated as stacked bars to a total of 100%
(Figure 4A). It was apparent that the percentages of cari-
ous lesions in the second permanent molars in both
control and probiotic groups increased in almost all
tooth surfaces during this 12-month study and that the
pit and fissure caries in both groups was more preva-
lent in our cohort than was caries in the other four
smooth surfaces, including mesial, distal, buccal and
lingual (Figure 4A). Sums of the percentages of caries
increment for all five tooth surfaces, including the pit
and fissure surface and four smooth surfaces, and for
four smooth surfaces in the probiotic group versus the
control group were 25.5 versus 44.2 and 15.2 versus
21.4, respectively (Figure 4B). The percentages of caries
increment only in the pit and fissure surface were 10.3
versus 22.8 (Figure 4B). Interestingly, the percentage of
new caries occurrence for all five tooth surfaces (OR =
1.605; 95% CI 1.007–2.557; p = 0.045) and for the pit
and fissure surface (OR = 2.582; 95% CI 1.235–5.400;
p = 0.01) was significantly lower in the probiotic group
than that in the control group, whereas there was no sig-
nificant difference in new caries occurrence between two
groups for the four smooth surfaces (OR = 1.506; 95% CI
0.726–3.126; p = 0.269).
Figure 3 Significant but transient reduction in salivary mutans streptococci (MS) counts by probiotic intervention. The linear graph
illustrates mean log counts of MS (open circles) and those of lactobacilli (LB; black circles) in the unit of cfu/ml (y-axis) in both probiotic (solid lines) and
control (dotted lines) groups from four different periods of saliva collection (x-axis): T0, T3, T6 and T12. * = p < 0.05; ** = p < 0.01; *** = p < 0.001. Error
bars represent standard errors (SE). The values of mean log MS and LB counts and (SE) are shown in the solid boxes for the probiotic group and in the
dotted boxes for the control group in each period of saliva collection.
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and decreased numbers of MS
Correlations between each pair of salivary HNP1-3 levels
in μg/mg of total protein, MS counts and LB counts in
log cfu/ml in both control and probiotic groups were de-
termined by the Pearson Correlation test (see Additional
file 1 for the data of each parameter), and it was revealed
that significant correlations between these parameters
were only found in the probiotic group, but not in the
control group (Figure 5). Particularly, salivary HNP1-3
levels were positively correlated with LB counts (r =
0.376; p < 0.001; Figure 5B) with the equation from the
regression analysis: y = 0.653x + 5.929, where y is the log
LB count and x is the HNP1-3 level, whereas LB counts
were inversely associated with MS counts (r = −0.282;
p = 0.002; Figure 5F). Nevertheless, no significant cor-
relation was noted between salivary HNP1-3 levels and
MS counts in the probiotic group (Figure 5D), suggest-
ing that enhanced salivary HNP1-3 levels by the pro-
biotic intervention are not associated with decreased
MS quantities.
Discussion
The main findings from this study include (a) a signifi-
cant but temporary increase in salivary HNP1-3 levels at
T3 and T6 in the probiotic group; (b) a significant in-
crease in LB counts as opposed to a transient decrease
in MS counts during probiotic intervention; (c) positive
and negative correlations found between HNP1-3 levelsand LB counts and between LB counts and MS counts,
respectively, in the probiotic group; and (d) a significant
reduction in caries increment for the pit and fissure sur-
face, not for the smooth surfaces. Among these four
major findings, the significant increase in salivary
HNP1-3 levels by probiotic supplementation during the
six-month intervention period is of great interest since it
is probable that Lactobacillus paracasei SD1 may exert
an immunostimulatory effect by enhanced production of
innate immune effectors, especially HNP1-3, from ductal
epithelial cells of submandibular salivary glands [19],
which are then secreted into the saliva. The possible
immunostimulatory effect of Lactobacillus paracasei
SD1 warrants further investigations. In addition, the in-
nate immune activation by Lactobacillus paracasei SD1
is corroborated with the significant correlation between
elevated salivary HNP1-3 levels and increased LB counts
seen in Figure 5B. Activation of host immunity, particu-
larly increased production of secretory immunoglobulin
A (sIgA), has been previously shown to be one of the
principal mechanisms for probiotics in the gastrointes-
tinal tracts [26-28] and in the oral cavity [29-31]. In this
study, the rationale to investigate only the salivary
HNP1-3 levels during probiotic intervention was based
on the observation from a single previous study that
demonstrated significantly higher HNP1-3 levels in the
saliva samples from caries-free children than those from
caries-susceptible children [19]. However, it is necessary
to further determine the salivary levels of other
Figure 4 Significant decrease in the percentage of caries increment for the pit and fissure surface, but not for the smooth surfaces, by
probiotic intervention. (A) The 100% stacked bars demonstrate the percentages of sound (white area; ICDAS score =0) and unsound (filled
areas; ICDAS scores =1–6) surfaces from all five tooth surfaces, including pit and fissure, mesial, distal, buccal, and lingual, in the control (upper
panel) and the probiotic (lower panel) groups. Note higher percentages of unsound surfaces in the pit and fissure surface than those in the other
four surfaces. (B) The bar graph reveals significant reduction in the percentages of caries increment in the probiotic group for a combination of
all five tooth surfaces and for the pit and fissure surface alone, but not for the combined four smooth surfaces, including mesial, distal, buccal
and lingual surfaces. * = p < 0.05; ** = p = 0.01.
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microbial peptides besides HNP1-3, in a future study. It
is noted that the levels of salivary HNP1-3 detected in
our cohort were comparable to those measured by the
same ELISA method performed by Tao and co-workers
[19]. Interestingly, the HNP1-3 levels were temporarily
elevated during the six-month intervention period and
gradually declined to the baseline levels after cessation
of probiotic intake. The temporary induction of HNP1-3
levels was in line with the transient induction of sIgA
levels in saliva by probiotic intake [30], indicating that
daily consumption of probiotics seems to be required for
a sustainable increase in host immune responses.
Nevertheless, the raised salivary HNP1-3 levels did not
significantly correlate with the decreased MS counts, but
the LB counts were instead correlated inversely with the
MS counts, suggesting that the mechanism for probiotic
action in the oral cavity may probably involve the com-
petition and/or the interaction between two distinctmicroorganisms as previously shown by Teanpaisan and
Piwat [22] rather than enhanced production of HNP1-3.
It is worthwhile to note that the inverse correlation be-
tween MS and LB counts was weak, so this suggests that
other factors that were not tested in this study, such as
different MS strains recovered from different individuals
[32], may play a role in the regulation of MS numbers
by LB. In contrast to no significant change in MS counts
in the control group, it was evident that the MS counts
were transiently decreased in the probiotic group at T3
and T6, consistent with the finding from a previous
study [33]. This, again, confirms the short-lasting effect
of probiotics against MS numbers, similar to the transi-
ent increasing effect on HNP1-3 levels. It is interesting
to note a prolonged increase in LB counts irrespective of
the cessation of probiotic intervention, which may be ex-
plained by the ability of Lactobacillus paracasei SD1 to
be retained in the oral cavity, as previously reported [22]
and by the counting method for total LB on MRS agar
Figure 5 Positive and negative correlations between salivary human neutrophil peptide (HNP) 1–3 levels and log counts of lactobacilli
(LB) and between log counts of mutans streptococci (MS) and those of LB, respectively, in the probiotic group. The correlation
coefficients (r) and the significance levels (p-values) between each pair of three parameters, including HNP1-3 levels in μg/mg, LB counts in log cfu/ml
and MS counts in log cfu/ml were determined and illustrated for both control (A, C and E) and probiotic (B, D and F) groups. The regression analysis
could be determined only for the significant correlation between increased HNP1-3 levels and increased LB counts in B, and a regression line was
drawn with the equation: y = 0.653x + 5.929; p = 0.003.
Wattanarat et al. BMC Oral Health  (2015) 15:19 Page 8 of 11in this study, rather than the specific quantification of
Lactobacillus paracasei SD1. Consequently, it is possible
that the increased MS counts back to the baseline levels
at 12 months were attributable to the absence of Lacto-
bacillus paracasei SD1, although the total LB counts
were still high. In this study, we did not examine the
morphology of LB recovered from saliva samples in
great detail with Gram stain, although some colonies of
LB on MRS plates were randomly selected and checked
for the presence of Lactobacillus paracasei SD1 by aqualitative assay like Arbitrarily Primed-Polymerase
Chain Reaction fingerprints [22]. Therefore, the inability
to confirm the morphology of LB and to quantitatively
compare the levels of Lactobacillus paracasei SD1 be-
tween the control and probiotic groups at each time
point is a limitation of this study and this inability may
preclude the possibility of Lactobacillus paracasei SD1
retention in the oral cavity.
In addition to the laboratory results regarding HNP1-3
levels and microbial counts in saliva, we extended our
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increment in our cohort. The significant reduction by
approximately 2.6 fold for caries increment within
12 months was observed for the pit and fissure caries in
the probiotic group when compared with the control
group (Figure 4B), suggesting that probiotic intervention
in milk powder helps reduce the occurrence of new cari-
ous lesions for the pit and fissure surface. In addition to
considering the pit and fissure surface alone, the sum of
the percentages for caries increment in all five tooth sur-
faces was also significantly reduced in the probiotic
group (Figure 4B). These results differ from the findings
from two previous studies, which demonstrated a low
odds ratio for caries prevention on occlusal surfaces
from milk containing Lactobacillus rhamnosus GG in
preschool children [25] and lack of significant difference
in new caries occurrence between the probiotic and con-
trol groups [34]. A possible explanation for this discrep-
ancy is that the participants in each of those studies
were categorized as low caries risk, whereas half of the
participants in our study were categorized as high caries
risk, according to the modified criteria for caries assess-
ment mentioned in the Methods. Therefore, as sug-
gested by the results of those studies and ours, probiotic
intervention may be beneficial to reduce the new occur-
rence of pit and fissure caries in children with high car-
ies risk.
In this study, it was demonstrated that the probiotic
intervention did not reduce new caries occurrence on
the smooth surfaces. This may be explained by the fact
that pit and fissure caries is more associated with MS
quantities than is smooth surface caries, consistent with
the critical role of MS in pit and fissure caries develop-
ment [35]. Moreover, it was apparent that the effect of
probiotics on smooth surface caries varied among differ-
ent smooth surfaces (Figure 4A). Particularly, the pro-
biotics appeared to have a caries-reducing effect on the
distal and lingual surfaces, but not on the mesial and
buccal surfaces. Nevertheless, such mixed effects did not
reach a statistically significant level when sum of the
percentages for caries increment in four smooth sur-
faces was determined (Figure 4B). Some factors that
can influence distinct outcomes between occlusal and
smooth surface caries and then preclude statistical veri-
fication include the location of second permanent mo-
lars (whether in maxillae or in mandibles), the sample
size, and the 12-month duration of this study. There-
fore, it is suggested that a larger study with a longer
follow-up duration and with special attention to the
tooth location be further conducted to more precisely
verify all of the statistically significant and non-
significant findings and to define the extent and mech-
anism behind any observable beneficial effects from
probiotic intervention.Utilizing non-sweetened milk powder as a suitable ve-
hicle to introduce the probiotics in this study provided
several health benefits for the participants, including
provision of more nutrients, good compliance, and add-
itional caries prevention from some constituents in milk
powder, such as casein, calcium and phosphorous [36].
Moreover, among several different LB species that have
been reported as probiotics, it has been previously
shown that Lactobacillus paracasei exerted a maximum
inhibitory effect on MS [15,16], possibly by its ability to
produce paracasin SD1 that functions against MS in the
oral cavity [37]. Furthermore, compared with various
probiotic strains used in other studies, predominantly
isolated from the gastrointestinal tract [33,34,38,39],
Lactobacillus paracasei SD1 used in our study was iso-
lated from the oral cavity of caries-free volunteers. How-
ever, this probiotic strain could only exert a temporary
effect on MS reduction and HNP1-3 induction despite a
prolonged increase in LB counts in the saliva samples.
This may be because the colony counting method on
MRS agar cannot differentiate our probiotic strain from
other LB strains that already reside in the participants’
mouths. Otherwise, it is probable that our probiotic
strain can possibly increase the number of other LB
strains, a possibility that warrants further investigations.
Although cariogenic progression varies between differ-
ent individuals and sometimes lasts longer than a year,
the 12-month randomized and double-blinded clinical
trial was designed in order to control different inherent
factors between the control and probiotic groups. Add-
itionally, the ICDAS was chosen as a tool to assess cari-
ous lesions in this short period of study because it is
sensitive enough to detect an early carious lesion [40].
Further studies into the underlying mechanisms of in-
creased HNP1-3 production by our probiotics in differ-
ent oral cell types are currently being investigated, and
additional studies into the activation of other oral im-
mune effectors classified in acquired and innate immun-
ity are essential to verify the real potential benefits and
applications of probiotics for good oral health, especially
for caries prevention. Several confounding factors that
were beyond our control in each individual, including
variations in the baseline levels of salivary HNP1-3, in
the different quantities and strains of MS, in the quan-
tities of fermentable carbohydrate consumption, and in
the quality of oral hygiene care, are noted and may affect
the outcomes of this study.
Conclusions
Probiotic supplementation with Lactobacillus paracasei
SD1 can temporarily enhance salivary HNP1-3 levels
and decrease the numbers of MS. The significant correl-
ation, found between increased LB counts and decreased
MS counts, suggests that probiotic action may involve
Wattanarat et al. BMC Oral Health  (2015) 15:19 Page 10 of 11the competition or interaction between two distinct mi-
croorganisms. In this study, the increment of pit and
fissure caries, but not of smooth surface caries, was di-
minished by probiotic supplementation in the form of
milk powder.
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